These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8307142)

  • 21. [In vitro amphotericin B susceptibility of korean bloodstream yeast isolates assessed by the CLSI broth microdilution method, Etest, and Minimum fungicidal concentration test].
    Park JY; Shin JH; Uh Y; Kim EC; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Korean J Lab Med; 2008 Oct; 28(5):346-52. PubMed ID: 18971615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms.
    Kohler LM; Soares BM; de Assis Santos D; Da Silva Barros ME; Hamdan JS
    Can J Microbiol; 2006 Sep; 52(9):843-7. PubMed ID: 17110976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relevance of antifungal resistance.
    Espinel-Ingroff A
    Infect Dis Clin North Am; 1997 Dec; 11(4):929-44. PubMed ID: 9421708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Antimicrob Agents Chemother; 1997 May; 41(5):1124-6. PubMed ID: 9145880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
    Mínguez Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
    Liu D; Liang L; Chen J
    J Infect Chemother; 2013 Aug; 19(4):776-8. PubMed ID: 23104584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
    Alvarado-Ramírez E; Torres-Rodríguez JM
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2420-3. PubMed ID: 17438048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeirão Preto, São Paulo, Brazil.
    Pedroso RS; Ferreira JC; Candido RC
    Mem Inst Oswaldo Cruz; 2006 May; 101(3):239-43. PubMed ID: 16862315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs.
    Caligiorne RB; Resende MA; Melillo PH; Peluso CP; Carmo FH; Azevedo V
    Med Mycol; 1999 Dec; 37(6):405-9. PubMed ID: 10647121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
    Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
    J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanization and morphological effects on antifungal susceptibility of Penicillium marneffei.
    Kaewmalakul J; Nosanchuk JD; Vanittanakom N; Youngchim S
    Antonie Van Leeuwenhoek; 2014 Nov; 106(5):1011-20. PubMed ID: 25227777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
    Yamazumi T; Kuroda T; Ohata T; Obana Y; Furuta I
    Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug susceptibility of 64 strains of Rhodotorula sp.
    Krzyściak P; Macura AB
    Wiad Parazytol; 2010; 56(2):167-70. PubMed ID: 20707302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases.
    Sanchotene KO; Brandolt TM; Klafke GB; Poester VR; Xavier MO
    Med Mycol; 2017 Nov; 55(8):869-876. PubMed ID: 28472490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans.
    Shawar R; Paetznick V; Witte Z; Ensign LG; Anaissie E; LaRocco M
    J Clin Microbiol; 1992 Aug; 30(8):1976-81. PubMed ID: 1500502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
    Dannaoui E; Colin S; Pichot J; Piens MA
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):228-32. PubMed ID: 9131326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.